Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. LEQEMBI (lécanémab) 
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

LEQEMBI (lécanémab) 

Medicine - Posted on Sep 09 2025
Active substance (DCI)
  • lécanémab
history (1)
  • 9/4/25

    LEQEMBI (lécanémab) - maladie d'Alzheimer

    Refus d’accès précoce de la spécialité LEQEMBI (lécanémab) dans l'indication « Traitement des patients adultes présentant un...
    icône flèche
Technical information
ATC code
  • N06DX04
Manufacturer
EISAI SAS
Presentation

LEQEMBI (lécanémab) 100 mg/mL, solution à diluer pour perfusion
B/1 flacon de 2 ml (CIP : 34009 551 058 6 2)
B/1 flacon de 5 ml (CIP : 34009 551 058 7 9)

All our publications
    Alzheimer’s disease and mental disorders Central nervous system diseases Drug therapy Geriatrics Neurodegenerative diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
mdc3qUrrgEhyhcM5